News

From on-stage demos to expo floor chit chat, attendees couldn't resist discussing what data collection and analysis could bring to consumer healthcare technology.

The clearance is a first for the relatively underserved epilepsy wearable space.

"This last year has been a year of rebuilding, creating infrastructure, [and] ensuring that we have all of the guardrails,"  Outcome Health's Nandini Ramani said at CES 2019.

Earlier this week, AWAK Technologies (AWAK), a Singapore-headquartered medical technology company focused on dialysis using regeneration technology for end-stage renal disease, announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to its AWAK Peritoneal Dialysis (AWAK PD) device, a wearable and ultra-portable PD system that incorporates AWAK’s patented sorbent technology.

Launched in 2010 with a $25 million Series A financing led by Third Rock Ventures, Foundation Medicine released its first commercial assay called FoundationOne in 2012.

.

.

.

Users will be able to make refill requests, locate pharmacies, and even chat with a pharmacist without leaving Propeller's app.

Also: Pritzker Group Venture Capital announces slew of promotions and Grand Rounds taps former USF chief medical officer Dr. Ami Parekh for same role.